Bio-Matrix Scientific Group, Inc. Contracts & Agreements

A promissory note executed on June 23, 2022 in favor of Ralph Davis in the amount of $25,000.00 (Filed With SEC on July 25, 2022)

A promissory note executed on June 23, 2022 in favor of Steven Wheeler in the amount of $35,000 (Filed With SEC on July 25, 2022)

A promissory note executed on June 28, 2022 in favor of Ralph Davis in the amount of $10,000.00 (Filed With SEC on July 25, 2022)

A promissory note executed on May 26, 2022 in favor of Aaron Klugman in the amount of $50,000.00 (Filed With SEC on July 11, 2022)

A promissory note executed on June 1, 2022 in favor of Aaron Klugman in the amount of $50,000.00 (Filed With SEC on July 11, 2022)

A promissory note executed on June 1, 2022 in favor of David Crosser in the amount of $20,000.00 (Filed With SEC on July 11, 2022)

A promissory note executed on June 8, 2022 in favor of David Crosser in the amount of $60,000.00 (Filed With SEC on July 11, 2022)

A lease agreement between the registrant and the landlord Restart Western Skies, L.P. expiring on June 30 2025 (Filed With SEC on July 11, 2022)

A promissory note executed on June 15, 2022 in favor of Ralph Davis in the amount of $50,000.00 (Filed With SEC on July 11, 2022)

Settlement Agreement between the Company and Geneva Roth Remark Holdings, Inc., dated February 8, 2022 (Filed With SEC on May 18, 2022)

Amendment to Settlement Agreement between the Company and Geneva Roth Remark Holdings, Inc., dated April 19, 2022 (Filed With SEC on May 18, 2022)

Mutual Release between the Company and Geneva Roth Remark Holdings, Inc., dated April 27, 2022 (Filed With SEC on May 18, 2022)

Settlement Agreement between Rivulet Media, Inc. and Geneva Roth Remark Holdings, Inc., dated February 8, 2022 (Filed With SEC on February 17, 2022)

Form of Promissory Note (Filed With SEC on January 31, 2022)

Form of Promissory Note (Filed With SEC on November 29, 2021)

Form of Convertible Promissory Note (Filed With SEC on November 29, 2021)

Form of Series A Convertible Promissory Note (Filed With SEC on November 29, 2021)

Form of Multiple Advance Promissory Note (Filed With SEC on November 29, 2021)

Commercial Loan Agreement between Rivulet Films, Inc. and Topps, LLC dated September 16, 2021 (Filed With SEC on November 29, 2021)

Collateral Security Agreement between Rivulet Films, Inc. and Topps, LLC dated September 16, 2021 (Filed With SEC on November 29, 2021)

Negotiable Secured Promissory Note between Rivulet Films, Inc. and Topps, LLC dated September 16, 2021 (Filed With SEC on November 29, 2021)

Stock Sale Agreement between the Company and Mr. Witherill dated September 27, 2021 (Filed With SEC on November 29, 2021)

Loan Agreement and Promissory Note between the Company and Mr. Witherill dated September 27, 2021 (Filed With SEC on November 29, 2021)

Stock Sale Agreement between the Company and Mr. Larson dated November 9, 2021 (Filed With SEC on November 29, 2021)

Loan Agreement and Promissory Note between the Company and Mr. Larson dated November 9, 2021 (Filed With SEC on November 29, 2021)

Termination Agreement between the Company and Mr. Witherill dated November 8, 2021 (Filed With SEC on November 29, 2021)

Promissory Note dated June 2, 2021 (Filed With SEC on June 21, 2021)

Amendment to Promissory Note dated April 29, 2021 (Filed With SEC on May 10, 2021)

Promissory Note dated May 7, 2021 (Filed With SEC on May 10, 2021)

Promissory Note dated April 20, 2021 (Filed With SEC on April 22, 2021)

Amendment to Life Story Rights Agreement dated June 1, 2020 (Filed With SEC on March 22, 2021)

Amendment to Employment Agreement between Rivulet Films, Inc., Rivulet Media, Inc., Paris Film, Inc. and Rob Paris dated March 1, 2021 (Filed With SEC on March 22, 2021)

Promissory Note (Filed With SEC on March 3, 2021)

Form of Amendment to Promissory Note (Filed With SEC on March 2, 2021)

Form of Amendment to Promissory Note (Filed With SEC on February 26, 2021)

PROMISSORY NOTE (Filed With SEC on February 10, 2021)

Form of Promissory Note (Filed With SEC on January 28, 2021)

Amendment to Employment Agreement (Filed With SEC on January 28, 2021)

PROMISSORY NOTE (Filed With SEC on January 14, 2021)

SUBSCRIPTION AGREEMENT RIVULET MEDIA, INC. (Filed With SEC on January 4, 2021)

SERIES A CONVERTIBLE PROMISSORY NOTE RIVULET MEDIA, INC. (Filed With SEC on January 4, 2021)

SUBSCRIPTION AGREEMENT RIVULET MEDIA, INC. (Filed With SEC on January 4, 2021)

PROMISSORY NOTE (Filed With SEC on December 10, 2020)

PROMISSORY NOTE (Filed With SEC on December 3, 2020)

Form of Stock Option Agreement (Filed With SEC on November 12, 2020)

2020 Equity Incentive Plan (Filed With SEC on November 12, 2020)

Promissory Note dated October 29, 2020, made by Rivulet Media, Inc. to Daniel Crosser (Filed With SEC on November 12, 2020)

Multiple Advance Promissory Note (Filed With SEC on October 30, 2020)

Security Agreement (Filed With SEC on October 30, 2020)

s/ Mike Witherill (Filed With SEC on October 30, 2020)

Form of Subscription Agreement for Convertible Promissory Note (Filed With SEC on October 22, 2020)

Form of Convertible Promissory Note (Filed With SEC on October 22, 2020)

Form of Subscription Agreement for Common Stock (Filed With SEC on October 22, 2020)

EMPLOYMENT AGREEMENT (Filed With SEC on August 17, 2020)

Promissory Note dated April 7, 2020, made by Blue Scout Enterprises payable to Rivulet Films LLC (Filed With SEC on July 1, 2020)

Assignment of Promissory Note dated effective as of April 16, 2020 (Filed With SEC on July 1, 2020)

AGREEMENT AND PLAN OF MERGER by andamong RIVULET MEDIA, INC., aDelaware corporation, MAUGHAN MUSIC, INC., aDelaware corporation, and MAUGHAN MUSIC GROUP LLC, anArizona limited... (Filed With SEC on June 5, 2020)

LIFE STORY RIGHTS AGREEMENT (Filed With SEC on May 28, 2020)

EMPLOYMENT AGREEMENT (Filed With SEC on May 28, 2020)

AGREEMENTAND PLAN OF MERGER byand among BIO-MATRIXSCIENTIFIC GROUP, INC., aDelaware corporation, RIVULETFILMS, INC., aDelaware corporation, and RIVULETFILMS LLC, anArizona limited... (Filed With SEC on April 13, 2020)

Note Payable $6,000 (Filed With SEC on February 28, 2020)

Note Payable $2,039 (Filed With SEC on February 28, 2020)

Note Payable $600 (Filed With SEC on February 28, 2020)

Note Payable $1,236 (Filed With SEC on February 28, 2020)

Note Payable $1,000 (Filed With SEC on December 12, 2019)

Note Payable $62,00 (Filed With SEC on December 12, 2019)

Note Payable $10,000 (Filed With SEC on December 12, 2019)

Note Payable $100 (Filed With SEC on December 12, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 27, 2016)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on August 8, 2016)

INDEMNIFICATIONAGREEMENT (Filed With SEC on July 7, 2016)

ENGAGEMENTAGREEMENT (Filed With SEC on June 8, 2016)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 9, 2016)

RESEARCHCOLLABORATION AGREEMENT (Filed With SEC on December 17, 2015)

UNITPURCHASE AGREEMENT REGENBIOPHARMA, INC. (Filed With SEC on November 24, 2015)

AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIM (Filed With SEC on November 5, 2015)

EMPLOYMENTAGREEMENT BETWEEN REGENBIOPHARMA, INC. AND HarryM. Lander, Ph.D., M.B.A. (Filed With SEC on October 13, 2015)

AMENDMENTTO LICENSE AGREEMENT DATED APRIL 6, 2015 (Filed With SEC on August 26, 2015)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on August 11, 2015)

AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND SANTOSH KESARI (Filed With SEC on August 11, 2015)

AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. (Filed With SEC on June 26, 2015)

CONVERTIBLE PROMISSORYNOTE (Filed With SEC on May 13, 2015)

ConsultingAgreement (Filed With SEC on March 30, 2015)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on March 25, 2015)

AppendixA DESIGNATEDLEASED SPACE - FLOOR PLAN (Filed With SEC on March 25, 2015)

RESEARCHAGREEMENT (Filed With SEC on March 25, 2015)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on March 10, 2015)

PATENTPURCHASE AGREEMENT (Filed With SEC on March 10, 2015)

EMPLOYMENTAGREEMENT BETWEEN REGENBIOPHARMA, INC. AND TODDS. CAVEN (Filed With SEC on February 13, 2015)

EMPLOYMENTAGREEMENT BETWEEN REGENBIOPHARMA, INC. AND DavidR. Koos (Filed With SEC on February 13, 2015)

THESECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION ORTHE SECURITIES COMMISSION OF ANY STATE PURSUANT... (Filed With SEC on February 10, 2015)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 10, 2015)

CONVERTIBLE PROMISSORYNOTE (Filed With SEC on February 10, 2015)

EMPLOYMENTAGREEMENT BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIM (Filed With SEC on January 22, 2015)

EMPLOYMENTAGREEMENT BETWEEN REGEN BIOPHARMA, INC AND CHRISTINE ICHIM (Filed With SEC on January 22, 2015)

AMENDMENTTO SUBLEASE AGREEMENT (AGREEMENT) ENTERED INTO OCTOBER 1, 2014 BY AND BETWEEN ENTEST BIOMEDICAL, INC. ( SUBLESSOR)AND REGEN BIOPHARMA,INC (SUBTENANT) (Filed With SEC on January 22, 2015)

ASSIGNMENT OF INVENTION ANDPATENT APPLICATION (Filed With SEC on December 29, 2014)

ConsultingAgreement (Filed With SEC on December 29, 2014)

SUBLEASE AGREEMENT (Filed With SEC on December 29, 2014)

STOCKPURCHASE AGREEMENT (Filed With SEC on November 7, 2014)

PROMISSORY NOTE PAYABLE (Filed With SEC on August 13, 2014)

Regen BioPharma Inc. A wholly owned subsidiary of Bio-Matrix ScientificGroup Inc. (Filed With SEC on January 7, 2014)

REGEN BIO PHARMA INC. A wholly owned subsidiary of Bio matrix ScientificGroup, Inc. (Filed With SEC on January 7, 2014)

SERVICE AGREEMENT (Filed With SEC on October 1, 2013)

LICENSE AGREEMENT - EXECUTION (Filed With SEC on August 6, 2013)

Exclusive License Agreement Between OHSU and Regen BioPharma, INC For Invention Disclosure 0472 1.BACKGROUND 22.DEFINITIONS23.GRANT OF RIGHTS 54.PAYMENTS 65.SUBLICENSING... (Filed With SEC on June 12, 2013)

SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on March 12, 2013)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 28, 2012)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 28, 2012)

EMPLOYMENT AGREEMENT BETWEEN BIO-MATRIX SIENTIFIC GROUP, INC. AND THOMAS ICHIM (Filed With SEC on June 28, 2012)

Exclusive Option to Negotiate an Exclusive License Between Oregon Health & Science University and Regen BioPharma, Inc. (Filed With SEC on June 6, 2012)

Regen BioPharma Inc. A wholly owned subsidiary of Bio-Matrix Scientific Group Inc. (Filed With SEC on May 31, 2012)

Letter of Intent between Clinartis, LLC, and Regen BioPharma, Inc. May 30, 2012 (Filed With SEC on May 31, 2012)

REGEN BIO PHARMA INC. A wholly owned subsidiary of Bio matrix Scientific Group, Inc. (Filed With SEC on May 24, 2012)

EQUITY PURCHASE AGREEMENT BY AND BETWEEN BIO-MATRIX SCIENTIFIC GROUP, INC. AND SOUTHRIDGE PARTNERS II, LP Dated April 23, 2012 (Filed With SEC on May 8, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 8, 2012)

EMPLOYMENT AGREEMENT BETWEEN BIO-MATRIX SIENTIFIC GROUP, INC. AND J. CHRISTOPHER MIZER (Filed With SEC on May 8, 2012)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 26, 2012)

Principal Amount: $50,000.00 Issue Date: December 15, 2011 Purchase Price: $50,000.00 CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 7, 2012)

/s/David Koos /s/Stephen Josephs Bio-Matrix Scientific Group Inc. Therinject LLC By Its: CEO By Its: Executive Manager David R. Koos Steven Josephs EXHIBIT A: (Filed With SEC on August 25, 2009)

STOCK PURCHASE AGREEMENT (Filed With SEC on June 22, 2009)

CONSULTINGAGREEMENT (Filed With SEC on April 30, 2009)

SEPARATIONAND DISTRIBUTION AGREEMENT (Filed With SEC on April 30, 2009)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 7, 2008)

Category

Industry

Companies

Contracts

Bio-Matrix Scientific Group, Inc. Contracts & Agreements